Australian Drug Maker Has Low Profile but Powerful Backers in Washington

Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.

from NYT > Health http://ift.tt/2iRDacl
via health&fitness